Journal
INFLAMMATORY BOWEL DISEASES
Volume 22, Issue 1, Pages 241-247Publisher
OXFORD UNIV PRESS INC
DOI: 10.1097/MIB.0000000000000598
Keywords
inflammatory bowel disease; fibrosis; stricture; disease course; stenosis; reversibility
Categories
Funding
- Faculty of Medicine, Westfalische Wilhelms-Universitat Munster
- National Institutes of Health [T32DK083251, P30DK097948]
- European Crohn's and Colitis Foundation
Ask authors/readers for more resources
Intestinal fibrosis is a common feature of Crohn's disease and may appear as a stricture, stenosis, or intestinal obstruction. Fibrostenosing Crohn's disease leads to a significantly impaired quality of life in affected patients and constitutes a challenging treatment situation. In the absence of specific medical antifibrotic treatment options, endoscopic or surgical therapy approaches with their potential harmful side effects are frequently used. However, our understanding of mechanisms of fibrogenesis in general and specifically intestinal fibrosis has emerged. Progression of fibrosis in the liver, lung, or skin can be halted or even reversed, and possible treatment targets have been identified. In face of this observation and given the fact that fibrotic alterations in various organs of the human body share distinct core characteristics, this article aims to address whether reversibility of intestinal fibrosis may be conceivable and to highlight promising research avenues and therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available